Literature DB >> 663627

EXAFS: new horizons in structure determinations.

P Eisenberger, B M Kincaid.   

Abstract

Although the phenomena of extended x=ray absorption fine structure (EXAFS) were observed as early as the 1930's, EXAFS has only recently, with the utilization of synchrotron radiation, been transformed into a powerful structural technique. The theory and experimental practice of the technique are described and illustrated with data on germanium. Applications to systems as diverse as hemoglobin, polymer-bound catalysts, ions in solution, amorphous solids, and adsorbate atoms on surfaces are reviewed. With the recent approval of funding for new, more powerful dedicated synchrotron sources, the future holds the possibility of a virtual revolution in structure determinations.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 663627     DOI: 10.1126/science.663627

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  Calcium environment in bone mineral determined by EXAFS spectroscopy.

Authors:  J E Harries; D W Hukins; S S Hasnain
Journal:  Calcif Tissue Int       Date:  1988-10       Impact factor: 4.333

2.  EXAFS study of structural disorder in carbonate-containing hydroxyapatites.

Authors:  J E Harries; S S Hasnain; J S Shah
Journal:  Calcif Tissue Int       Date:  1987-12       Impact factor: 4.333

3.  The electronic structure of Fe2+ in reaction centers from Rhodopseudomonas sphaeroides. II. Extended x-ray fine structure studies.

Authors:  P Eisenberger; M Y Okamura; G Feher
Journal:  Biophys J       Date:  1982-02       Impact factor: 4.033

Review 4.  X-ray absorption spectroscopy.

Authors:  Junko Yano; Vittal K Yachandra
Journal:  Photosynth Res       Date:  2009 Nov-Dec       Impact factor: 3.573

5.  Propagation of uncertainty in experiment: structures of Ni (II) coordination complexes.

Authors:  Martin J Schalken; Christopher T Chantler
Journal:  J Synchrotron Radiat       Date:  2018-05-30       Impact factor: 2.616

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.